Can-Fite BioPharma Ltd. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Property, Plant and Equipment, Net

12 Months Ended

Dec. 31, 2019

NOTE 8:- PROPERTY, PLANT AND EQUIPMENT, NET

Balance as of December 31, 2019:

	Laboratory equipment		Computers, office furniture and equipment		Leasehold improvements		Total
	USD
Cost:

Balance at January 1, 2019	$	39	$	190	$	12	$	241
Purchases during the year		-		3		-		3

Balance at December 31, 2019		39		193		12		244

Accumulated depreciation:

Balance at January 1, 2019		18		170		6		194
Depreciation during the year		5		8		1		14

Balance at December 31, 2019		23		178		7		208

Depreciated cost at December 31, 2019	$	16	$	15	$	5	$	36

Balance as of December 31, 2018:

	Laboratory equipment		Computers, office furniture and equipment		Leasehold improvements		Total
	USD
Cost:

Balance at January 1, 2018	$	22	$	180	$	6	$	208
Purchases during the year		17		10		6		33

Balance at December 31, 2018		39		190		12		241

Accumulated depreciation:

Balance at January 1, 2018		14		161		5		180
Depreciation during the year		4		9		1		14

Balance at December 31, 2018		18		170		6		194

Depreciated cost at December 31, 2018	$	21	$	20	$	6	$	47

For the years ended December 31, 2019 and 2018, depreciation expenses were $14 for both periods.